肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

提升前列腺癌分期准确性:68Ga-PSMA PET/CT影像与初治患者组织病理学分级的关联性研究

Enhancing Prostate Cancer Staging: Association of 68Ga-PSMA PET/CT Imaging with Histopathological Grading in Treatment-Naive Patients

原文发布日期:18 October 2024

DOI: 10.3390/cancers16203526

类型: Article

开放获取: 是

 

英文摘要:

Objective: This study aimed to evaluate the correlation between 68Ga-PSMA uptake in PSMA PET/CT in primary prostate cancer (PC) and its histopathological grading (Gleason score and ISUP grade). Additionally, we compared preoperative biopsy histopathological findings with definitive pathology results in radical prostatectomy (RP) specimens. Methods: We retrospectively analyzed 86 patients who underwent 68Ga-PSMA PET/CT for primary PC staging, of which 40 patients later underwent radical prostatectomy. PET/CT results, including SUVmax values, were correlated with GS and PSA concentrations. Histopathology reports were analyzed and compared between biopsy and final pathology results following RP. Results: A significant positive correlation was observed between SUVmax and ISUP grades (Pearson’s ρ = 0.34,p< 0.001), with higher SUVmax values associated with more advanced grades. A cut-off SUVmax value of 5.64 was determined to predict upstaging in patients, yielding a sensitivity of 76% and a specificity of 60% (AUC = 0.82, 95% CI: 0.70–0.94). Additionally, 57.5% of patients experienced a grade shift following RP, with a 35% upgrade and 22.5% downgrade in ISUP grades. Conclusion: 68Ga-PSMA PET/CT demonstrated high sensitivity in detecting high-risk prostate cancer, particularly in patients with GS > 7 or PSA levels ≥ 10 ng/mL. The findings suggest that this imaging modality may be less effective for the staging of patients with lower GS or PSA values, that is, low-risk PCa. Further prospective studies are necessary to validate these results.

 

摘要翻译: 

目的:本研究旨在评估原发性前列腺癌(PC)患者68Ga-PSMA PET/CT中PSMA摄取与组织病理学分级(格里森评分及ISUP分级)之间的相关性。同时,我们比较了术前活检组织病理学结果与根治性前列腺切除术(RP)标本的最终病理结果。方法:我们回顾性分析了86例因原发性前列腺癌分期而行68Ga-PSMA PET/CT检查的患者,其中40例后续接受了根治性前列腺切除术。将PET/CT结果(包括SUVmax值)与格里森评分及PSA浓度进行相关性分析。对活检与RP术后最终病理结果的组织病理学报告进行了分析与比较。结果:SUVmax与ISUP分级呈显著正相关(Pearson’s ρ = 0.34, p < 0.001),SUVmax值越高,分级越晚。确定SUVmax截断值为5.64可用于预测患者分级上调,其敏感性为76%,特异性为60%(AUC = 0.82,95% CI:0.70–0.94)。此外,57.5%的患者在RP术后出现分级变化,其中ISUP分级上调占35%,下调占22.5%。结论:68Ga-PSMA PET/CT在检测高危前列腺癌方面表现出高敏感性,尤其适用于格里森评分 > 7 或PSA水平 ≥ 10 ng/mL的患者。研究结果表明,该影像学方法对于格里森评分或PSA值较低(即低危前列腺癌)患者的分期可能效果有限。需进一步开展前瞻性研究以验证这些结果。

 

原文链接:

Enhancing Prostate Cancer Staging: Association of 68Ga-PSMA PET/CT Imaging with Histopathological Grading in Treatment-Naive Patients

广告
广告加载中...